Kyle D. Kuvalanka

Overview

Kyle D. Kuvalanka received an average of $994K in total compensation, including $243K in salary, at Syros Pharmaceuticals between 2015 and 2016.

Source: SEC filing on April 25, 2017.

Related executives

We found seven more executives who work or worked at Syros Pharmaceuticals.

Nancy Simonian

Syros Pharmaceuticals

Chief Executive Officer

Eric Olson

Syros Pharmaceuticals

Chief Scientific Officer

David Roth

Syros Pharmaceuticals

Chief Medical Officer

Jason Haas

Syros Pharmaceuticals

Chief Financial Officer

Joseph Ferra

Syros Pharmaceuticals

Chief Financial Officer

Jeremy Springhorn

Syros Pharmaceuticals

Chief Business Officer

Gerald Quirk

Syros Pharmaceuticals

Chief Legal Officer

You may also like